Cellular Orthopedics Blog
Regenerative Medicine Reflections
By an Evidence-Based Cellular Orthopedic Surgeon Memorial Day has come and gone. On May 31, the FDA finally started enforcing many of its rules; and Amniotic Fluid, for the time being, is no longer considered FDA compliant. Gone too are all the other biologic...
Memorial Day and Regenerative Medicine
By an Evidence-Based Cellular Orthopedic Surgeon The Food and Drug Administration has pledged that after May 31, 2021, the agency will broadly enforce requirements that developers of regenerative medicine products — therapies intended to repair or replace damaged...
Cellular Orthopedics for Osteoarthritis
From Upcoming Treatments to Treatments Yet to Come On Saturday, I graduate into yet another decade of my life’s journey. In this Blog, instead of looking back, I will look to the future. The U.S. Food and Drug Administration plays a vital role in facilitating the...
Biologic Injections for Arthritis
On May 31st of 2021, the FDA will finally bring clarity, hopefully, to the discipline of Regenerative Medicine by enforcing the rules and regulations initially announced in the fall of 2017. With said enforcement, I hope and pray that there will be a restoration of...
Most Current Therapies for Osteoarthritis Only Address Symptoms
We Treat the Causes Limited treatment options for Osteoarthritis exist, and the current therapies are all palliative. They only address the symptoms but fail to address the root cause: cartilage damage from the activity of degradative enzymes (proteases) that destroy...
Personalized Stem Cells Announces Stem Cell Knee Arthritis FDA-Approved Phase 1/2a Clinical Trial Results
Personalized Stem Cells, Inc (PSC), a clinical-stage biopharma cell therapy company, announces the results of its single knee osteoarthritis phase 1/2a clinical trial. The final study report has been submitted to the FDA for review and in support of a full-scale...
On Biologics and Stem Cells for the Shoulder
Last weekend, I was pedaling my bike along State Highway 131 in Wisconsin, between Viola and LaFarge, when I was reminded by a warning sign of the number of recent requests from patients regarding their shoulder symptoms and limitations. After the year-long...
The Cellular Orthopedic Town Crier
Last Friday night, I was involved in a conference call with Personalized Stem Cells Inc., to review the outcomes of the first FDA-approved, Adipose Based, Stem Cell Trial and to assist in planning the second trial for knee arthritis. We hope to initiate the second...
The Lasting Benefits of Biologics in Arthritic Knees
I have previously shared with readers of this Blog, the fact that about eight weeks ago, in anticipation of a Colorado ski trip, I personally underwent an orthobiologics injection into both of my arthritic knees. Those biologic injections with proteins termed Growth...
A Novel Alternative to Traditional Joint Replacement
Recent randomized controlled trials covering several hundred patients with approximately 15-year follow-up have documented that biologic repair of subchondral lesions for patients with osteoarthritis and osteonecrosis is a viable alternative to total knee...
Orthobiologics (Growth Factors and Stem Cells) Helped Make It Possible
The Thrill of Yesteryear Powered by Orthobiologics On Saturday, my wife, oldest son, granddaughter, and I returned from a six-day ski trip to Vail Colorado. I skied five out of five days. While avoiding moguls and the advanced expert runs, I humbly admit that on fresh...
How Long Will The Bone Marrow Concentrate Benefits Last?
On Tuesday, a patient presented with a problematic left knee. She had been walking her dogs when she was attacked by a pit bull. In escaping, her left knee twisted violently, and over the past several weeks, the pain, limp, and swelling have remained. In reviewing her...